Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-8 can reduce skin rashes from cancer treatment.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Skin and mucous symptoms are key for diagnosing autoimmune connective tissue diseases.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

The rash resolved after stopping ponatinib.

Topical glucocorticoids thin the skin and change collagen structure.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

Recognizing unusual skin, eye, or hair issues can help diagnose immune system disorders early, especially in children.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Lasers can trigger skin reactions, especially in darker skin, and more research is needed to improve treatments.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Early-stage skin substitutes improve wound healing and skin structure.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.